Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences

被引:97
作者
Wang, XS
Lee, S
Simmons, Z
Boyer, P
Scott, K
Liu, WL
Connor, J
机构
[1] Penn State Coll Med, GM Leader Family Lab Alzheimers Dis Res, Dept Neurosurg H110, Hershey, PA 17033 USA
[2] Penn State Coll Med, Dept Neurol, Hershey, PA 17033 USA
[3] SW Texas State Univ, Dept Pathol, Div Neuropathol, Dallas, TX 75390 USA
[4] SW Texas State Univ, Dept Hlth Evaluat Sci, Dallas, TX 75390 USA
关键词
oxidative stress; iron; Hfe mutation; SOD1;
D O I
10.1016/j.jns.2004.08.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The etiology of amyotrophic lateral sclerosis (ALS) is unknown. The presence of mutations in the superoxide dismutase gene (SOD I) has led to theories regarding a role for oxidative stress in the pathogenesis of this disease. A primary cause of oxidative stress is perturbations in cellular iron homeostasis. Cellular iron mismanagement and oxidative stress are associated with a number of neurodegenerative diseases. One mechanism by which cells fail to properly regulate their iron status is through a mutation in the We gene. Mutations in the We gene are associated with the iron overload disease, hemochromatosis. In the current study, 31% of patients with sporadic ALS carried a mutation in the Hfe gene, compared to only 14% of patients without identifiable neuromuscular disease, or with neuromuscular diseases other than ALS (p<0.005). To determine the cellular consequences of carrying an Hfe mutation, a human neuronal cell line was transfected with genes carrying the Hfe mutation. The presence of the We mutation disrupted expression of tubulin and actin at the protein levels potentially consistent with the disruption of axonal transport seen in ALS and was also associated with a decrease in CuZnSOD1 expression. These data provide compelling evidence for a role for the Hfe mutation in etiopathogenesis of ALS and warrant further investigation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 36 条
[11]   Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis [J].
Cudkowicz, ME ;
McKennaYasek, D ;
Sapp, PE ;
Chin, W ;
Geller, B ;
Hayden, DL ;
Schoenfeld, DA ;
Hosler, BA ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1997, 41 (02) :210-221
[12]   Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism [J].
Dekker, MCJ ;
Giesbergen, PC ;
Njajou, OT ;
van Swieten, JC ;
Hofman, A ;
Breteler, MMB ;
van Duijn, CM .
NEUROSCIENCE LETTERS, 2003, 348 (02) :117-119
[13]   Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis [J].
Farah, CA ;
Nguyen, MD ;
Julien, JP ;
Leclerc, N .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (01) :77-86
[14]   The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding [J].
Feder, JN ;
Penny, DM ;
Irrinki, A ;
Lee, VK ;
Lebrón, JA ;
Watson, N ;
Tsuchihashi, Z ;
Sigal, E ;
Bjorkman, PJ ;
Schatzman, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1472-1477
[15]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[16]   The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression [J].
Feder, JN ;
Tsuchihashi, Z ;
Irrinki, A ;
Lee, VK ;
Mapa, FA ;
Morikang, E ;
Prass, CE ;
Starnes, SM ;
Wolff, RK ;
Parkkila, S ;
Sly, WS ;
Schatzman, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14025-14028
[17]   A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 [J].
Hadano, S ;
Hand, CK ;
Osuga, H ;
Yanagisawa, Y ;
Otomo, A ;
Devon, RS ;
Miyamoto, N ;
Showguchi-Miyata, J ;
Okada, Y ;
Singaraja, R ;
Figlewicz, DA ;
Kwiatkowski, T ;
Hosler, BA ;
Sagie, T ;
Skaug, J ;
Nasir, J ;
Brown, RH ;
Scherer, SW ;
Rouleau, GA ;
Hayden, MR ;
Ikeda, JE .
NATURE GENETICS, 2001, 29 (02) :166-173
[18]   FINE-STRUCTURAL STUDY OF NEUROFIBRILLARY CHANGES IN A FAMILY WITH AMYOTROPHIC LATERAL SCLEROSIS [J].
HIRANO, A ;
NAKANO, I ;
KURLAND, LT ;
MULDER, DW ;
HOLLEY, PW ;
SACCOMANNO, G .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1984, 43 (05) :471-480
[19]   Geography of HFE C282Y and H63D mutations [J].
Merryweather-Clarke, AT ;
Pointon, JJ ;
Jouanolle, AM ;
Rochette, J ;
Robson, KJH .
GENETIC TESTING, 2000, 4 (02) :183-198
[20]   Global prevalence of putative haemochromatosis mutations [J].
MerryweatherClarke, AT ;
Pointon, JJ ;
Shearman, JD ;
Robson, KJH .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) :275-278